Gala Biotech, Inc.
Gala Biotech, Inc. has developed enabling technology for the production of pharmaceutical proteins. The company’s Transgametic technology introduces reengineered retrovectors to cattle to create transgenic embryos that ultimately result in cows that express the desired protein in their milk.
After receiving start-up financing from venture capital firms including Advantage Capital Partners and operating for nearly three years, the Company entered into a strategic relationship with Cardinal Health, Inc. (NYSE: CAH), the leading provider of products and services supporting the health care industry, to fully leverage Gala’s proprietary gene insertion technology. Upon the formation of the relationship, Cardinal Health invested $12 million in the company to expand Galas operations and accelerate its business development efforts. Subsequent to its initial investment after Gala met certain milestones Cardinal agreed to acquire the remaining portion of the company that it did not own as part of its ongoing strategy to grow and enhance its range of innovative drug development services.
Silicon Logic Engineering, Inc.
Eau Claire, Wisconsin
Silicon Logic Engineering, Inc. is a semiconductor design services company that provides Application Specific Integrated Circuit (ASIC), System on Chip (SOC), and system technology services to the world’s leading electronic systems and fabless semiconductor companies.
The co-investor is Stonehenge Capital.
TomoTherapy has developed, manufactures and sells the Hi-Art® system, one of the most advanced and versatile radiation therapy systems commercially available for the treatment of a wide variety of cancers. TomoTherapy markets the Hi-Art® system to university research centers, hospitals, private and governmental institutions and cancer treatment centers in North America, Europe and Asia. The company had its Initial Public Offering in May 2007 and trades on NASDAQ (TOMO).